nad has been researched along with Diabetic Nephropathies in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 7 (43.75) | 2.80 |
| Authors | Studies |
|---|---|
| Corremans, R; D'Haese, PC; Verhulst, A; Vervaet, BA | 1 |
| Bian, C; Ren, H | 1 |
| Li, P; Li, S; Liu, T; Ma, F; Mao, H; Wang, Y; Yang, L; Zhan, Y | 1 |
| Chen, Y; Li, C; Li, L; Li, R; Li, Z; Liang, X; Shi, Q; Si, M; Wu, Y; Yang, Y; Zhang, L; Zhang, Y; Zhao, X | 1 |
| Albanese, C; Bansal, S; Brodsky, L; Cheema, A; Ginley, B; Guha, U; Hirschey, MD; Jang, Y; Jones, BA; Kopp, JB; Krawczyk, E; Levi, M; Ma, J; Myakala, K; Na, CH; Panov, J; Qi, Y; Rosenberg, AZ; Sarder, P; Shults, NV; Wang, XX; Wu, C; Yang, X; Yoshida, T; Zhang, X | 1 |
| Hasegawa, K; Itoh, H; Kanda, T; Kawaguchi, T; Kusahana, E; Muraoka, H; Ono, T; Sakamaki, Y; Tokuyama, H; Wakino, S; Yasuda, I | 1 |
| Griffin, MD; Hyndman, KA | 1 |
| Hasegawa, K | 1 |
| Filipowski, H; Laszki-Szcząchor, K; Pilecki, W; Polak-Jonkisz, D; Rehan, L; Sobieszczańska, M | 1 |
| De Feo, V; Dewanjee, S; Gangopadhyay, M; K Dua, T; Khanra, R; Sahu, R; Zia-Ul-Haq, M | 1 |
| Dutta, RK; Kanwar, YS; Sun, L; Xie, P | 1 |
| Cooper, ME; Coughlan, MT; Forbes, JM | 1 |
| Kanwar, YS; Oates, PJ; Srivastava, SK; Sun, L; Xie, P | 1 |
| Flynn, CT; Shadur, CA | 1 |
| Monnier, VM; Rosca, MG; Szweda, LI; Weiss, MF | 1 |
| Baier, LD; Harlow, JE; Ostrow, E; Smith, SR; Tilton, RG; Williamson, JR | 1 |
5 review(s) available for nad and Diabetic Nephropathies
| Article | Year |
|---|---|
Sirtuin Family and Diabetic Kidney Disease.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Humans; Kidney; Mitochondria; NAD; Sirtuins | 2022 |
Sirtuins as novel pharmacological targets in podocyte injury and related glomerular diseases.
Topics: Diabetic Nephropathies; Humans; NAD; Podocytes; Proteinuria; Sirtuins; Transcription Factors | 2022 |
Novel tubular-glomerular interplay in diabetic kidney disease mediated by sirtuin 1, nicotinamide mononucleotide, and nicotinamide adenine dinucleotide Oshima Award Address 2017.
Topics: Animals; Awards and Prizes; Claudin-1; Diabetic Nephropathies; Epigenesis, Genetic; Gene Expression Regulation; Glucose Transporter Type 2; Humans; Kidney Glomerulus; Kidney Tubules; NAD; Nicotinamide Mononucleotide; Signal Transduction; Sirtuin 1; Sodium-Glucose Transporter 2 | 2019 |
Nephroprotective action of sirtuin 1 (SIRT1).
Topics: Animals; Apoptosis; Autophagy; Blood Pressure; Catalase; Diabetic Nephropathies; Energy Metabolism; Gene Expression; Humans; Isoenzymes; Kidney; NAD; Oxidation-Reduction; Protective Agents; Sirtuin 1 | 2013 |
Oxidative stress as a major culprit in kidney disease in diabetes.
Topics: Animals; Cytosol; Diabetic Nephropathies; Disease Models, Animal; Energy Metabolism; Glucose; Glucosephosphate Dehydrogenase; Glycation End Products, Advanced; Glycolysis; Humans; Mitochondria; NAD; Oxidation-Reduction; Oxidative Phosphorylation; Oxidative Stress; Reactive Oxygen Species; Sorbitol | 2008 |
11 other study(ies) available for nad and Diabetic Nephropathies
| Article | Year |
|---|---|
L-NAME Administration Enhances Diabetic Kidney Disease Development in an STZ/NAD Rat Model.
Topics: Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Male; NAD; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar | 2021 |
Aberrant NAD synthetic flux in podocytes under diabetic conditions and effects of indoleamine 2,3-dioxygenase on promoting de novo NAD synthesis.
Topics: Diabetes Mellitus; Diabetic Nephropathies; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Ligases; NAD; Podocytes | 2023 |
NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; DNA, Mitochondrial; Inflammation; Interferons; Mice; Mitochondria; NAD; Nucleotidyltransferases | 2023 |
Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy.
Topics: Albuminuria; Animals; Claudin-1; Cytokines; Diabetic Nephropathies; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; Dose-Response Relationship, Drug; Epigenesis, Genetic; Glomerular Mesangium; Glycated Hemoglobin; Histones; Male; Mice; Mice, Knockout; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Nicotinamide-Nucleotide Adenylyltransferase; Podocytes; Sirtuin 1; Survival Rate; Time Factors | 2021 |
Could NAD
Topics: Diabetes Mellitus; Diabetic Nephropathies; Dietary Supplements; Humans; NAD; Sirtuin 1 | 2021 |
Abroma augusta L. (Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response.
Topics: Adenosine Triphosphate; Animals; Biomarkers; Blood Glucose; Body Weight; Cardiomyopathies; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; DNA Fragmentation; Glucose Tolerance Test; Inflammation; Kidney; Male; Malvaceae; Myocardium; NAD; Niacinamide; Organ Size; Oxidative Stress; Phytochemicals; Plant Extracts; Plant Leaves; Rats, Wistar | 2015 |
myo-Inositol Oxygenase Overexpression Accentuates Generation of Reactive Oxygen Species and Exacerbates Cellular Injury following High Glucose Ambience: A NEW MECHANISM RELEVANT TO THE PATHOGENESIS OF DIABETIC NEPHROPATHY.
Topics: Animals; Diabetic Nephropathies; Glucose; Hydrogen Peroxide; Inositol Oxygenase; Kidney; LLC-PK1 Cells; Male; Mice; Mitochondria; NAD; Oxidative Stress; Reactive Oxygen Species; Swine; Up-Regulation | 2016 |
Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis.
Topics: Aldehyde Reductase; Animals; Cadherins; Diabetic Nephropathies; Disease Models, Animal; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibronectins; Fibrosis; Glucose; Inositol Oxygenase; Kidney Tubules; LLC-PK1 Cells; Male; Mice; Mice, Inbred C57BL; NAD; Phosphorylation; Protein Kinase C-alpha; Protein Prenylation; Protein Transport; raf Kinases; ras Proteins; RNA Interference; Signal Transduction; Swine; Transfection; Transforming Growth Factor beta1; Vimentin | 2010 |
A comparison of continuous ambulatory peritoneal dialysis in diabetic and nondiabetic patients.
Topics: Adolescent; Adult; Aged; Blood Glucose; Child; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Lipids; Middle Aged; NAD; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1981 |
Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal.
Topics: Adenosine Diphosphate; Animals; Diabetic Nephropathies; Electron Transport; Kidney; Mitochondria; Mitochondrial Proteins; NAD; Pyruvaldehyde; Rats; Rats, Sprague-Dawley; Succinic Acid | 2002 |
Diabetes-induced glomerular dysfunction: links to a more reduced cytosolic ratio of NADH/NAD+.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Cytosol; Diabetic Nephropathies; In Vitro Techniques; Kidney Glomerulus; Male; NAD; Oxidation-Reduction; Rats; Rats, Inbred Strains | 1992 |